See also this year's filing and all EDGAR filings for this company.
PDF Report 0001365216_2012_Sucampo_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001365216, Sucampo Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 114,916,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 8,364,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,669,000 |
| 3 | remainder_Assets | 32,620,000 |
| 4 | LiabilitiesCurrent | 47,081,000 |
| 5 | LiabilitiesNoncurrent | 2,603,000 |
| 6 | remainder_Liabilities | 69,291,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 41,270,000 |
| 9 | ResearchAndDevelopmentExpense | 33,497,000 |
| 10 | remainder_Expenses | -6,925,000 |
| 11 | remainder_Revenues | 54,761,000 |
| 12 | remainder_NetIncome | -4,225,000 |
| 13 | remainder_ComprehensiveNetIncome | 1,280,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 157,569,000 |
| 1 | Liabilities | 118,975,000 |
| 2 | Expenses | 67,842,000 |
| 3 | Revenues | 54,761,000 |
| 4 | StockholdersEquity | 38,594,000 |
| 5 | NetIncome | -17,306,000 |
| 6 | ComprehensiveNetIncome | -16,666,000 |
| 7 | BaseVar | 202,326,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.488 |
| 9 | EconomicCapitalRatio | 1.87 |
Edgar->Model Mapping
Feature Distribution
